Mark van Oene - 10 Aug 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting relationship: President & CEO
Issuer ticker: PACB
Reported as of: 10 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2026, 17:54:52 UTC
Prior SEC filing: 04 Mar 2026
Next SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Brett Atkins, Attorney-in-fact

Key filing fact

Mark van Oene filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 11 Aug 2026.

Key facts

This page summarizes Mark van Oene's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Aug 2026, 17:54.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707477 Primary reporting owner

Van Oene Mark

Relationship: President & CEO
Address: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK
Signature: /s/ Brett Atkins, Attorney-in-fact
Signature date: 11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PACB transaction

Common Stock

Award

Transaction value
Shares: +489,130
Change %: +22%
Price: $0.000000^*
Shares after: 2,732,764
Date: 10 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PACB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +1,967,888
Change %
Price: $0.000000^*
Shares after: 1,967,888
Date: 10 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,967,888
Exercise price: $1.15
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on August 10 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Footnote F2

The shares subject to the option will vest in 36 equal monthly installments beginning on September 10, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

SEC remarks

President & CEO